PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

Drug side effects

vancomycin Side Effects

The reactions most often reported to the FDA for vancomycin (also sold as Vancocin), with demographics, serious outcomes, and reporting trends.

Data updated 2026-05-15

55,549
FAERS reports

Data from the FDA Adverse Event Reporting System (FAERS), 1999 to 2025. A FAERS report records a temporal association, not proof of cause. See our methodology for how figures are compiled and de-duplicated.

The most commonly reported side effects of vancomycin come from 55,549 reports to the FDA, broken down here by frequency, patient demographics, and serious outcomes.

This page analyzes 55,549 reports to the FDA Adverse Event Reporting System (FAERS) for vancomycin (Vancocin): the reactions reported most often, who reported them, serious outcomes such as hospitalization, and year-over-year trends. A FAERS report does not prove the drug caused the effect, and report volume tracks how widely a drug is used, not how likely an effect is for any one person. Educational information, not medical advice.

Total Reports

55,549

Reports Mentioning Death

11,029

19.9% of reports — not proof the medicine caused the death

Hospitalizations

30,109

54.2% of reports

Top Indication

Product Used For Unknown Indication

Most Reported Adverse Reactions

ACUTE KIDNEY INJURY
4,178
PYREXIA
3,514
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS
2,311
RENAL FAILURE
2,198
SEPSIS
2,062
DIARRHOEA
2,034
PNEUMONIA
1,906
HYPOTENSION
1,882
RASH
1,821
CONDITION AGGRAVATED
1,807
DYSPNOEA
1,605
SEPTIC SHOCK
1,557
NAUSEA
1,534
THROMBOCYTOPENIA
1,526
PAIN
1,478
RESPIRATORY FAILURE
1,376
NEUTROPENIA
1,317
RENAL IMPAIRMENT
1,300

Who Reports Side Effects

Gender Distribution

Female 22,837 (46%)
Male 27,005 (54%)
Unknown 278

Age Distribution

0-17 5,614 (13%)
18-44 8,942 (20%)
45-64 15,132 (34%)
65-74 8,704 (19%)
75+ 6,293 (14%)

Reporting Trend by Year

1999 2025

Reactions in Death Reports

Top reactions reported in 11,029 reports where death was an outcome. These are voluntarily reported and do not establish causation.

Reaction Reports
DEATH 1,233
SEPSIS 1,034
SEPTIC SHOCK 990
RENAL FAILURE 956
MULTIPLE ORGAN DYSFUNCTION SYNDROME 866
RESPIRATORY FAILURE 833
PNEUMONIA 780
PYREXIA 721
ACUTE KIDNEY INJURY 675
HYPOTENSION 629
MULTI-ORGAN FAILURE 579
CONDITION AGGRAVATED 508
CARDIAC ARREST 507
PAIN 492
DIARRHOEA 456
RENAL IMPAIRMENT 422
THROMBOCYTOPENIA 420
DYSPNOEA 413

Reactions in Hospitalization Reports

Top reactions in 30,109 reports where hospitalization was an outcome.

Reaction Reports
ACUTE KIDNEY INJURY 2,777
PYREXIA 2,442
SEPSIS 1,441
PNEUMONIA 1,436
DIARRHOEA 1,361
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1,348
HYPOTENSION 1,295
RENAL FAILURE 1,239
DYSPNOEA 1,116
SEPTIC SHOCK 1,087
CONDITION AGGRAVATED 1,054
NAUSEA 1,049
THROMBOCYTOPENIA 1,027
RESPIRATORY FAILURE 974
VOMITING 933
RASH 922
FEBRILE NEUTROPENIA 920
ANAEMIA 875

Compare vancomycin vs amikacin →

What the FAERS Data Reveals About vancomycin Side Effects

The FDA Adverse Event Reporting System (FAERS) contains 55,549 voluntary reports linked to vancomycin and its brand equivalents (Vancocin), spanning 1999 through 2025. Of those, 11,029 (19.9%) listed death as an outcome and 30,109 (54.2%) involved hospitalization. The most common indication reported alongside adverse events was Product Used For Unknown Indication.

Demographic breakdowns help contextualize who is being exposed to the drug. Of reports with known sex, 46% were female and 54% male; age distribution skews toward 45-64, with 15,132 reports in that bracket. The single most reported reaction is acute kidney injury with 4,178 submissions, followed by pyrexia and drug reaction with eosinophilia and systemic symptoms.

How to read these numbers

FAERS is a signal-detection tool, not a scorecard. Reports are voluntary, and a single case may list multiple suspect drugs, so numbers above should not be read as incidence rates or per-patient risk. Widely prescribed drugs naturally accumulate more reports than niche therapies even when individual risk is low. These aggregates are useful for spotting patterns that merit further pharmacovigilance, not for choosing between medications. This page is for educational reference only and is not medical advice, speak with a licensed clinician about any side-effect concerns.